FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Piet Geusens

Research Profile

Concepts & Ideas

Disorders

Procedures

Anatomy

Chemicals & Drugs

Physiology

Bone Resorption

Co-author Network

Publications

TOP 3
Mickael Hiligsmann; Jean-Yves Reginster; Trudy van der Weijden; Caroline van Durme; Benedict Gc Dellaert; Carmen D Dirksen; Piet Geusens; Annelies Boonen
Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis.
Philip N Sambrook; Piet Geusens
The epidemiology of osteoporosis and fractures in ankylosing spondylitis.
Piet Geusens
The role of RANK ligand/osteoprotegerin in rheumatoid arthritis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Piet Geusens (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Mickael Hiligsmann; Jean-Yves Reginster; Trudy van der Weijden; Caroline van Durme; Benedict Gc Dellaert; Carmen D Dirksen; Piet Geusens; Annelies Boonen
Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis.
Patient preference and adherence 2013;7():133-9.
2012: Philip N Sambrook; Piet Geusens
The epidemiology of osteoporosis and fractures in ankylosing spondylitis.
Therapeutic advances in musculoskeletal disease 2012;4(4):287-92.
2012: Piet Geusens
The role of RANK ligand/osteoprotegerin in rheumatoid arthritis.
Therapeutic advances in musculoskeletal disease 2012;4(4):225-33.
2012: Bieke Broux; Bert O Eijnde; Piet Geusens; Tom Broekmans; Silva Markovic-Plese; Kim Pannemans; Veerle Somers; Piet Stinissen; Susanne M A van der Pol; Jack van Horssen; Bart Van Wijmeersch; Xin Zhang; Niels Hellings
CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients.
Journal of autoimmunity 2012;38(1):10-9.
2012: Anke Wesselius; Ilja C W Arts; Martijn J L Bours; Piet Geusens; Esther H E Theunisz; Pieter C Dagnelie
The P2X(7) loss-of-function Glu496Ala polymorphism affects ex vivo cytokine release and protects against the cytotoxic effects of high ATP-levels.
BMC immunology 2012;13():64.
2011: Willem F Lems; Hennie G Raterman; Niek K Valk; Joop P W van den Bergh; M Carola Zillikens; Hans W J Bijlsma; Piet Geusens
Osteopenia: a diagnostic and therapeutic challenge.
Current osteoporosis reports 2011;9(3):167-72.
2011: F Heldmann; Robert Landewe; Marjatta Leirisalo-Repo; Joachim Listing; S Schewe; Joachim Sieper; F van den Bosch; I E van der Horst-Bruinsma; M Breban; Gerd R Burmester; kurt de vlam; Maxime Dougados; P Emery; H Gaston; Piet Geusens; T Appelboom; J Brandt; J Braun
The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab.
Clinical and experimental rheumatology 2011;29(4):672-80.
2011: Pui Yan Jenny Chung; Fenna de Freitas; Jean-Pierre Devogelaer; Piet Geusens; Stefan Goemaere; Jan F Van Offel; Filip Vanhoenacker; Leon Verbruggen; René Westhovens; Hans-Georg Zmierczak; Greet Beyens; Steven Boonen; Wim Van Hul
Indications for a genetic association of a VCP polymorphism with the pathogenesis of sporadic Paget's disease of bone, but not for TNFSF11 (RANKL) and IL-6 polymorphisms.
Molecular genetics and metabolism 2011;103(3):287-92.
2011: Nathan Vastesaeger; Désirée van der Heijde; Robert D Inman; Yanxin Wang; Atul Deodhar; Benjamin Hsu; Mahboob U Rahman; Ben Dijkmans; Piet Geusens; Bert Vander Cruyssen; Eduardo Collantes; Joachim Sieper; Jürgen Braun
Predicting the outcome of ankylosing spondylitis therapy.
Annals of the rheumatic diseases 2011;70(6):973-81.
2011: JAN COEN NETELENBOS; Piet Geusens; G Ypma; S J E Buijs
Adherence and profile of non-persistence in patients treated for osteoporosis--a large-scale, long-term retrospective study in The Netherlands.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2011;22(5):1537-46.
2011: Klaartje Somers; Piet Geusens; Dirk Elewaut; Filip De Keyser; Jean-Luc Rummens; Marieke Coenen; Marlies Blom; Piet Stinissen; Veerle Somers
Novel autoantibody markers for early and seronegative rheumatoid arthritis.
Journal of autoimmunity 2011;36(1):33-46.
2011: Piet Geusens; Willem F Lems
Osteoimmunology and osteoporosis.
Arthritis research & therapy 2011;13(5):242.
2010: Pui Yan Jenny Chung; Greet Beyens; Steven Boonen; Socrates Papapoulos; Piet Geusens; Marcel Karperien; Filip Vanhoenacker; Leon Verbruggen; Erik Fransen; Jan F Van Offel; Stefan Goemaere; Hans-Georg Zmierczak; René Westhovens; Jean-Pierre Devogelaer; Wim Van Hul
The majority of the genetic risk for Paget's disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes.
Human genetics 2010;128(6):615-26.
2010: Pui Yan Jenny Chung; Greet Beyens; Philip L Riches; Liesbeth Van Wesenbeeck; Fenna de Freitas; Karen Jennes; Anna Daroszewska; Erik Fransen; Steven Boonen; Piet Geusens; Filip Vanhoenacker; Leon Verbruggen; Jan F Van Offel; Stefan Goemaere; Hans Zmierczak; René Westhovens; Marcel Karperien; Socrates Papapoulos; Stuart H Ralston; Jean-Pierre Devogelaer; Wim Van Hul
Genetic variation in the TNFRSF11A gene encoding RANK is associated with susceptibility to Paget's disease of bone.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2010;25(12):2592-605.
2010: Elizabeth Shane; David Burr; Peter R Ebeling; Bo Abrahamsen; Robert A Adler; Thomas D Brown; Angela M Cheung; Felicia Cosman; Jeffrey R Curtis; Richard Dell; David Dempster; Thomas A Einhorn; Harry K Genant; Piet Geusens; Klaus Klaushofer; Kenneth Koval; Joseph M Lane; Fergus McKiernan; Ross McKinney; Alvin Ng; Jeri Nieves; Regis O'Keefe; Socrates Papapoulos; Howe Tet Sen; Marjolein C H van der Meulen; Robert S Weinstein; Michael Whyte
Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2010;25(11):2267-94.
2010: Mehrsheed Sinaki; Michael Pfeifer; E Preisinger; Eiji Itoi; René Rizzoli; Steven Boonen; Piet Geusens; Helmut W Minne
The role of exercise in the treatment of osteoporosis.
Current osteoporosis reports 2010;8(3):138-44.
2010: Lilian H D van Tuyl; Alexandre E Voskuyl; Maarten Boers; Piet Geusens; Robert B M Landewé; Ben A C Dijkmans; Willem F Lems
Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis.
Annals of the rheumatic diseases 2010;69(9):1623-8.
2010: Tim Nawrot; Piet Geusens; Tom S Nulens; Benoit Nemery
Occupational cadmium exposure and calcium excretion, bone density, and osteoporosis in men.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2010;25(6):1441-5.
2010: Piet Geusens; Tineke van Geel; Joop van den Bergh
Can Hip Fracture Prediction in Women be Estimated beyond Bone Mineral Density Measurement Alone?
Therapeutic advances in musculoskeletal disease 2010;2(2):63-77.
2010: Joop van den Bergh; Tineke van Geel; Piet Geusens
[Should the vitamin D level be determined for all fracture patients?].
Nederlands tijdschrift voor geneeskunde 2010;154():A1758.
2009: Piet Geusens
Strategies for treatment to prevent fragility fractures in postmenopausal women.
Best practice & research. Clinical rheumatology 2009;23(6):727-40.
2009: Debby Vosse; Robert Landewé; Désirée van der Heijde; Sjef van der Linden; Tjeerd P van Staa; Piet Geusens
Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study.
Annals of the rheumatic diseases 2009;68(12):1839-42.
2009: Piet Geusens
Glucocorticoid-induced osteoporosis: an indication for anabolic therapy.
Current osteoporosis reports 2009;7(3):71-2.
2009: Piet Geusens; Philip Sambrook; Willem Lems
Fracture prevention in men.
Nature reviews. Rheumatology 2009;5(9):497-504.
2009: Walter P Maksymowych; Oliver Fitzgerald; George A Wells; Dafna D Gladman; Robert Landewé; Mikkel Ostergaard; William J Taylor; Robin Christensen; Paul P Tak; Maarten Boers; Silje W Syversen; Joan M Bathon; Christopher J Ritchlin; Philip J Mease; Vivian P Bykerk; Patrick Garnero; Piet Geusens; Hani El-Gabalawy; Daniel Aletaha; Robert D Inman; Virginia Byers Kraus; Tore K Kvien; Désirée van der Heijde
Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design.
The Journal of rheumatology 2009;36(8):1792-9.
2009: Walter P Maksymowych; Robert Landewé; Paul P Tak; Christopher J Ritchlin; Mikkel Ostergaard; Philip J Mease; Hani El-Gabalawy; Patrick Garnero; Dafna D Gladman; Oliver Fitzgerald; Daniel Aletaha; Vivian P Bykerk; Joan M Bathon; Silje W Syversen; Maarten Boers; Piet Geusens; Robert D Inman; Virginia B Kraus; Tore K Kvien; William J Taylor; George A Wells; Désirée van der Heijde
Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria.
The Journal of rheumatology 2009;36(8):1785-91.
2009: Silje W Syversen; Robert Landewe; Désirée van der Heijde; Joan M Bathon; Maarten Boers; Vivian P Bykerk; Oliver Fitzgerald; Dafna D Gladman; Patrick Garnero; Piet Geusens; Hani El-Gabalawy; Robert D Inman; Virginia Kraus; Tore K Kvien; Philip J Mease; Mikkel Ostergaard; Christopher J Ritchlin; Paul P Tak; William J Taylor; Walter P Maksymowych
Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid arthritis: a systematic literature search on 5 candidate biomarkers.
The Journal of rheumatology 2009;36(8):1769-84.
2009: Piet Geusens
Naproxcinod, a new cyclooxygenase-inhibiting nitric oxide donator (CINOD).
Expert opinion on biological therapy 2009;9(5):649-57.
2009: Elke Geens; Piet Geusens; Johan Vanhoof; Hubert Berghs; Johan Praet; Greet Esselens; Simonne Lens; Jean-Pol Dufour; Marc Vandenberghe; Xavier Van Mullem; René Westhovens; Patrick Verschueren
Belgian rheumatologists' perception on eligibility of RA patients for anti-TNF treatment matches more closely Dutch rather than Belgian reimbursement criteria.
Rheumatology (Oxford, England) 2009;48(5):546-50.
2009: Tineke A C M van Geel; Piet Geusens; Bjorn Winkens; Jean-Pierre J E Sels; Geert-Jan Dinant
Measures of bioavailable serum testosterone and estradiol and their relationships with muscle mass, muscle strength and bone mineral density in postmenopausal women: a cross-sectional study.
European journal of endocrinology / European Federation of Endocrine Societies 2009;160(4):681-7.
2009: Piet Geusens
Bisphosphonates for postmenopausal osteoporosis: determining duration of treatment.
Current osteoporosis reports 2009;7(1):12-7.
2009: Tahir Masud; Michael McClung; Piet Geusens
Reducing hip fracture risk with risedronate in elderly women with established osteoporosis.
Clinical interventions in aging 2009;4():445-9.
2009: Kenneth G Saag; Piet Geusens
Progress in osteoporosis and fracture prevention: focus on postmenopausal women.
Arthritis research & therapy 2009;11(5):251.
2009: Piet Geusens
Emerging treatments for postmenopausal osteoporosis - focus on denosumab.
Clinical interventions in aging 2009;4():241-50.
2008: M E A L Kroese; G J C Schulpen; M C M Bessems; Johan L Severens; F J Nijhuis; Piet Geusens; Robert B M Landewé
Substitution of specialized rheumatology nurses for rheumatologists in the diagnostic process of fibromyalgia: a randomized controlled trial.
Arthritis and rheumatism 2008;59(9):1299-305.
2008: Jürgen Braun; Atulya A Deodhar; Ben Dijkmans; Piet Geusens; Joachim Sieper; Paul Williamson; Weichun Xu; Sudha Visvanathan; Daniel Baker; Neil Goldstein; Désirée van der Heijde
Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period.
Arthritis and rheumatism 2008;59(9):1270-8.
2008: Ravin Jugdaohsingh; Mario Calomme; Karen Robinson; Forrest Nielsen; Simon H C Anderson; Patrick D'Haese; Piet Geusens; Nigel Loveridge; Richard P H Thompson; Jonathan J Powell
Increased longitudinal growth in rats on a silicon-depleted diet.
Bone 2008;43(3):596-606.
2008: Kitty B J M Cleutjens; Birgit C G Faber; Mat Rousch; Ruben van Doorn; Tilman M Hackeng; Cornelis Vink; Piet Geusens; Hugo ten Cate; Johannes Waltenberger; Vadim Tchaikovski; Marc Lobbes; Veerle Somers; Anneke Sijbers; Darcey Black; Peter J E H M Kitslaar; Mat J A P Daemen
Noninvasive diagnosis of ruptured peripheral atherosclerotic lesions and myocardial infarction by antibody profiling.
The Journal of clinical investigation 2008;118(8):2979-85.
2008: A Caroline Heijckmann; Maya S P Huijberts; Erik J Schoon; Piet Geusens; Jolanda De Vries; Paul P C A Menheere; Eveline van der Veer; Bruce Wolffenbuttel; Reinhold W Stockbrugger; Bianca Dumitrescu; AC Nieuwenhuijzen Kruseman
High prevalence of morphometric vertebral deformities in patients with inflammatory bowel disease.
European journal of gastroenterology & hepatology 2008;20(8):740-7.
2008: Debby Vosse; Robert Landewé; P Garnero; Désirée van der Heijde; Sjef van der Linden; Piet Geusens
Association of markers of bone- and cartilage-degradation with radiological changes at baseline and after 2 years follow-up in patients with ankylosing spondylitis.
Rheumatology (Oxford, England) 2008;47(8):1219-22.
2008: Pui Yan Jenny Chung; Greet Beyens; Núria Guañabens; Steven Boonen; Socrates E Papapoulos; Marcel Karperien; Marelise Eekhoff; Liesbeth Van Wesenbeeck; Karen Jennes; Piet Geusens; Erwin Offeciers; Jan Van Offel; René Westhovens; Hans Zmierczak; Jean-Pierre Devogelaer; Wim Van Hul
Founder effect in different European countries for the recurrent P392L SQSTM1 mutation in Paget's Disease of Bone.
Calcified tissue international 2008;83(1):34-42.
2008: Piet Geusens; Bianca Dumitrescu; Tineke van Geel; Sven van Helden; Johan Vanhoof; Geert-Jan Dinant
Impact of systematic implementation of a clinical case finding strategy on diagnosis and therapy of postmenopausal osteoporosis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2008;23(6):812-8.
2008: A Caroline Heijckmann; Marjolein Drent; B Dumitrescu; Jolanda De Vries; AC Nieuwenhuijzen Kruseman; Bruce Wolffenbuttel; Piet Geusens; Maya S P Huijberts
Progressive vertebral deformities despite unchanged bone mineral density in patients with sarcoidosis: a 4-year follow-up study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008;19(6):839-47.
2008: Piet Geusens; Willem Lems
Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritis.
Therapeutics and clinical risk management 2008;4(2):337-44.
2008: Bianca Dumitrescu; Svenhjalmar van Helden; Rene ten Broeke; Arie Nieuwenhuijzen-Kruseman; Caroline Wyers; Gabriela Udrea; Sjef van der Linden; Piet Geusens
Evaluation of patients with a recent clinical fracture and osteoporosis, a multidisciplinary approach.
BMC musculoskeletal disorders 2008;9():109.
2008: A Caroline Heijckmann; Bianca Dumitrescu; AC Nieuwenhuijzen Kruseman; Piet Geusens; Bruce Wolffenbuttel; Jolanda De Vries; Marjolein Drent; Maya S P Huijberts
Quantitative ultrasound does not identify patients with an inflammatory disease at risk of vertebral deformities.
BMC musculoskeletal disorders 2008;9():72.
2007: Debby Vosse; C Heijckmann; Robert Landewé; Désirée van der Heijde; Sjef van der Linden; Piet Geusens
Comparing morphometric X-ray absorptiometry and radiography in defining vertebral wedge fractures in patients with ankylosing spondylitis.
Rheumatology (Oxford, England) 2007;46(11):1667-71.
2007: Svenhjalmar van Helden; Evelyne Cauberg; Piet Geusens; Bjorn Winkes; Trudy van der Weijden; Peter Brink
The fracture and osteoporosis outpatient clinic: an effective strategy for improving implementation of an osteoporosis guideline.
Journal of evaluation in clinical practice 2007;13(5):801-5.
2007: Tjeerd P van Staa; John A Kanis; Piet Geusens; Annelies Boonen; Hubert G M Leufkens; Cyrus Cooper
The cost-effectiveness of bisphosphonates in postmenopausal women based on individual long-term fracture risks.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2007;10(5):348-57.
2007: Tineke A C M van Geel; Piet Geusens; Ivo F Nagtzaam; Danny J M van der Voort; Cyril M J R Schreurs; P E L M Rinkens; Geert-Jan Dinant
Risk factors for clinical fractures among postmenopausal women: a 10-year prospective study.
Menopause international 2007;13(3):110-5.
2007: Mahboob U Rahman; Ingrid Strusberg; Piet Geusens; Alberto Berman; David Yocum; Daniel Baker; Carrie Wagner; John Han; René Westhovens
Double-blinded infliximab dose escalation in patients with rheumatoid arthritis.
Annals of the rheumatic diseases 2007;66(9):1233-8.
2007: Piet Geusens; Debby Vosse; Sjef van der Linden
Osteoporosis and vertebral fractures in ankylosing spondylitis.
Current opinion in rheumatology 2007;19(4):335-9.
2007: Piet Geusens; Willem F Lems
[Fracture prevention in postmenopausal women with osteoporosis by an annual infusion of zoledronic acid].
Nederlands tijdschrift voor geneeskunde 2007;151(26):1445-8.
2007: Johannes P van Hooff; Piet Geusens; Maarten Hl Christiaans
Screening for fracture risk is mandatory in renal transplant patients on even low-dose maintenance steroids.
Nature clinical practice. Nephrology 2007;3(6):314-5.
2007: Ron N J De Nijs; J W G Jacobs; Willem F Lems; R F J M Laan; Ale Algra; Albert Huisman; Erik Buskens; C E D de Laet; J C M Oostveen; Piet Geusens; G A W Bruyn; B A C Dijkmans; J W J Bijlsmat
[Alendronate more effective than alfacalcidol in the prevention of osteoporosis in patients with rheumatic disease who are starting glucocorticoid therapy].
Nederlands tijdschrift voor geneeskunde 2007;151(21):1178-85.
2007: J W G Jacobs; Ron N J De Nijs; Willem F Lems; Piet Geusens; R F J M Laan; Albert Huisman; Ale Algra; Erik Buskens; Lorenz C Hofbauer; Ans C M Oostveen; G A W Bruyn; B A C Dijkmans; J W J Bijlsma
Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.
The Journal of rheumatology 2007;34(5):1051-7.
2007: Marielle Thewissen; Veerle Somers; Katrien Venken; Loes Linsen; Pieter van Paassen; Piet Geusens; J G M C Damoiseaux; Piet Stinissen
Analyses of immunosenescent markers in patients with autoimmune disease.
Clinical immunology (Orlando, Fla.) 2007;123(2):209-18.
2007: A Caroline Heijckmann; Maya S P Huijberts; Jolanda De Vries; Paul P C A Menheere; Eveline van der Veer; Arie C Nieuwenhuijzen Kruseman; Bruce Wolffenbuttel; Piet Geusens; Marjolein Drent
Bone turnover and hip bone mineral density in patients with sarcoidosis.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / World Association of Sarcoidosis and Other Granulomatous Disorders 2007;24(1):51-8.
2007: Walter P Maksymowych; Robert Landewe; Maarten Boers; Patrick Garnero; Piet Geusens; Hani El-Gabalawy; Dick Heinegård; Virginia B Kraus; Virginia Krause; Stefan Lohmander; John R Matyas; Tore Saxne; Désirée van der Heijde
Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trials.
The Journal of rheumatology 2007;34(3):634-40.
2007: Stephanie O Keeling; Robert Landewe; Désirée van der Heijde; Joan M Bathon; Maarten Boers; Patrick Garnero; Piet Geusens; Hani El-Gabalawy; Robert D Inman; Virginia B Kraus; Tore K Kvien; Philip J Mease; Mikkel Ostergaard; Christopher T Ritchlin; Silje W Syversen; Walter P Maksymowych
Testing of the preliminary OMERACT validation criteria for a biomarker to be regarded as reflecting structural damage endpoints in rheumatoid arthritis clinical trials: the example of C-reactive protein.
The Journal of rheumatology 2007;34(3):623-33.
2007: Tjeerd P van Staa; Piet Geusens; B Zhang; Hubert G M Leufkens; A Boonen; Cyrus Cooper
Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids.
Rheumatology (Oxford, England) 2007;46(3):460-6.
2007: Catharina S J van Hooy-Corstjens; Sjoerd K Bulstra; Menno L W Knetsch; Piet Geusens; Roel Kuijer; Leo H Koole
Biocompatibility of a new radiopaque iodine-containing acrylic bone cement.
Journal of biomedical materials research. Part B, Applied biomaterials 2007;80(2):339-44.
2007: Piet Geusens; Geertjan Dinant
Integrating a gender dimension into osteoporosis and fracture risk research.
Gender medicine 2007;4 Suppl B():S147-61.
2007: Svenhjalmar van Helden; Caroline E Wyers; Pieter C Dagnelie; Martien C van Dongen; Gittie Willems; Peter R G Brink; Piet Geusens
Risk of falling in patients with a recent fracture.
BMC musculoskeletal disorders 2007;8():55.
2007: Frank P Luyten; Piet Geusens; Michel Malaise; L De Clerck; René Westhovens; Frank Raeman; D Vander Mijnsbrugge; L Mathy; Jean-Philippe Hauzeur; Filip De Keyser; Filip Van den Bosch
A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip.
Annals of the rheumatic diseases 2007;66(1):99-106.
2006: Piet Geusens; Willem F Lems; Harald J J Verhaar; Geraline Leusink; Stefan Goemaere; Hans Zmierczack; Jullet Compston
Review and evaluation of the Dutch guidelines for osteoporosis.
Journal of evaluation in clinical practice 2006;12(5):539-48.
2006: Ron N J De Nijs; J W G Jacobs; Willem F Lems; R F J M Laan; Ale Algra; Albert Huisman; Erik Buskens; Chris E D de Laet; Ans C M Oostveen; Piet Geusens; G A W Bruyn; B A C Dijkmans; J W J Bijlsma
Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis.
The New England journal of medicine 2006;355(7):675-84.
2006: Annelies Boonen; Sjef van der Linden; Piet Geusens; Debby Vosse
"Allegory of the world": the ankylosed back as a metaphor for coping in daily life.
Annals of the rheumatic diseases 2006;65(7):852.
2006: Debby Vosse; Désirée van der Heijde; Robert Landewé; Piet Geusens; Herman Mielants; Maxime Dougados; Sjef van der Linden
Determinants of hyperkyphosis in patients with ankylosing spondylitis.
Annals of the rheumatic diseases 2006;65(6):770-4.
2006: René Westhovens; David Yocum; John Han; Alberto Berman; Ingrid Strusberg; Piet Geusens; Mahboob U Rahman
The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: a large, randomized, placebo-controlled trial.
Arthritis and rheumatism 2006;54(4):1075-86.
2006: Antonia C M van Geel; Piet Geusens; Ivo F Nagtzaam; Cyril M J R Schreurs; Danny J M van der Voort; P E L M Rinkens; Arnold D M Kester; Geert-Jan Dinant
Timing and risk factors for clinical fractures among postmenopausal women: a 5-year prospective study.
BMC medicine 2006;4():24.
2006: Svenhjalmar van Helden; Jochen W L Cals; Fons Kessels; Peter Brink; Geert-Jan Dinant; Piet Geusens
Risk of new clinical fractures within 2 years following a fracture.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2006;17(3):348-54.
2006: E Pijpers; M van der Klauw; AC Nieuwenhuijzen Kruseman; Piet Geusens
Regarding the article "low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study", by Kaptoge et al.
Bone 2006;38(1):145; author reply 146-9.
2006: Robert B M Landewé; Piet Geusens; Désirée van der Heijde; Maarten Boers; Sjef van der Linden; P Garnero
Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysis.
Annals of the rheumatic diseases 2006;65(1):40-4.
2006: Ernst Feldtkeller; Debby Vosse; Piet Geusens; Sjef van der Linden
Prevalence and annual incidence of vertebral fractures in patients with ankylosing spondylitis.
Rheumatology international 2006;26(3):234-9.
2005: Piet Geusens; David Reid
Newer drug treatments: their effects on fracture prevention.
Best practice & research. Clinical rheumatology 2005;19(6):983-9.
2005: Nelson B Watts; Piet Geusens; Ian P Barton; Dieter Felsenberg
Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2005;20(12):2097-104.
2005: Marielle Thewissen; Loes Linsen; Piet Geusens; Jef Raus; Piet Stinissen
Impaired activation-induced telomerase activity in PBMC of early but not chronic rheumatoid arthritis patients.
Immunology letters 2005;100(2):205-10.
2005: A Caroline Heijckmann; Maya S P Huijberts; Piet Geusens; Jolanda De Vries; Paul P C A Menheere; Bruce Wolffenbuttel
Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive L-thyroxine therapy for differentiated thyroid carcinoma.
European journal of endocrinology / European Federation of Endocrine Societies 2005;153(1):23-9.
2005: Marielle Thewissen; Loes Linsen; Veerle Somers; Piet Geusens; Jef Raus; Piet Stinissen
Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients.
Annals of the New York Academy of Sciences 2005;1051():255-62.
2005: Marc C Hochberg; Desmond E Thompson; Dennis M Black; Sara A Quandt; Jane A Cauley; Piet Geusens; Philip Ross; Dan Baran
Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2005;20(6):971-6.
2005: Steven Boonen; Dirk Vanderschueren; Katrien Venken; Piet Geusens; Patrick Haentjens; S Mohan; D J Baylink; Roger Bouillon
Differences in exposure to stimulatory and inhibitory components of the insulin-like growth factor (IGF) system in patients with femoral neck versus trochanteric fracture.
Age and ageing 2005;34(2):175-8.
2005: Désirée van der Heijde; B A C Dijkmans; Piet Geusens; Joachim Sieper; Kimberly DeWoody; Paul Williamson; Jürgen Braun
Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).
Arthritis and rheumatism 2005;52(2):582-91.
2005: Loes Linsen; Marielle Thewissen; Kurt Baeten; Veerle Somers; Piet Geusens; Jef Raus; Piet Stinissen
Peripheral blood but not synovial fluid natural killer T cells are biased towards a Th1-like phenotype in rheumatoid arthritis.
Arthritis research & therapy 2005;7(3):R493-502.
2005: Yebin Jiang; Jenny Zhao; Piet Geusens; Er-Yuan Liao; Peter Adriaensens; Jan Gelan; Moïse Azria; Steven Boonen; Francine Caulin; John A Lynch; Xiaolong Ouyang; Harry K Genant
Femoral neck trabecular microstructure in ovariectomized ewes treated with calcitonin: MRI microscopic evaluation.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2005;20(1):125-30.
2005: Leon J Schurgers; Kirsten J F Teunissen; Marjo H J Knapen; Piet Geusens; Désirée van der Heijde; Martijn Kwaijtaal; Rob van Diest; Markus Ketteler; Cees Vermeer
Characteristics and performance of an immunosorbent assay for human matrix Gla-protein.
Clinica chimica acta; international journal of clinical chemistry 2005;351(1-2):131-8.
2004: Piet Geusens; RIEKE ALTEN; J Rovensky; Victor S Sloan; Gerhard Krammer; G Kralidis; P Richardson
Efficacy, safety and tolerability of lumiracoxib in patients with rheumatoid arthritis.
International journal of clinical practice 2004;58(11):1033-41.
2004: Debby Vosse; Ernst Feldtkeller; Jon Erlendsson; Piet Geusens; Sjef van der Linden
Clinical vertebral fractures in patients with ankylosing spondylitis.
The Journal of rheumatology 2004;31(10):1981-5.
2004: Thomas J Schnitzer; Jannie Beier; Piet Geusens; Paul Hasler; Sanjay K Patel; Ingo Senftleber; Xavier Gitton; Alan Moore; Victor S Sloan; Gyula Poór
Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: a phase II, four-week, multicenter, randomized, double-blind, placebo-controlled trial.
Arthritis and rheumatism 2004;51(4):549-57.
2004: Ann VanderBorght; Loes Linsen; Marielle Thewissen; Piet Geusens; Jef Raus; Piet Stinissen
Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand mRNA expression in patients with rheumatoid arthritis and healthy controls.
The Journal of rheumatology 2004;31(8):1483-90.
2004: Michael Pfeifer; Mehrsheed Sinaki; Piet Geusens; Steven Boonen; Elisabeth Preisinger; Helmut W Minne
Musculoskeletal rehabilitation in osteoporosis: a review.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2004;19(8):1208-14.
2004: Danny J M van der Voort; Piet Geusens; Geert-Jan Dinant
A cross-sectional study of postmenopausal women found an association between osteoporosis and past gastric surgery or oral corticosteroids.
Journal of clinical epidemiology 2004;57(5):533-8.
2004: Robert Landewé; Piet Geusens; Maarten Boers; Désirée van der Heijde; Willem F Lems; Johan teKoppele; Sjef van der Linden; Patrick Garnero
Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis.
Arthritis and rheumatism 2004;50(5):1390-9.
2004: Philip N Sambrook; Piet Geusens; C Ribot; J A Solimano; J Ferrer-Barriendos; Keavy A Gaines; Nadia Verbruggen; Mary E Melton
Alendronate produces greater effects than raloxifene on bone density and bone turnover in postmenopausal women with low bone density: results of EFFECT (Efficacy of FOSAMAX versus EVISTA Comparison Trial) International.
Journal of internal medicine 2004;255(4):503-11.
2004: Piet Geusens; Ron N J De Nijs; Willem F Lems; R F J M Laan; Ard Struijs; Tjeerd P van Staa; J W J Bijlsma
Prevention of glucocorticoid osteoporosis: a consensus document of the Dutch Society for Rheumatology.
Annals of the rheumatic diseases 2004;63(3):324-5.
2003: Johan Vanhoof; S Landewe; E Van Wijngaerden; Piet Geusens
High incidence of hepatotoxicity of isoniazid treatment for tuberculosis chemoprophylaxis in patients with rheumatoid arthritis treated with methotrexate or sulfasalazine and anti-tumour necrosis factor inhibitors.
Annals of the rheumatic diseases 2003;62(12):1241-2.
2003: Lavienja A J L M Braam; Marjo H J Knapen; Piet Geusens; Fred Brouns; Cees Vermeer
Factors affecting bone loss in female endurance athletes: a two-year follow-up study.
The American journal of sports medicine 2003;31(6):889-95.
2003: Piet Geusens
Review of guidelines for testing and treatment of osteoporosis.
Current osteoporosis reports 2003;1(2):59-65.
2003: P Garnero; Piet Geusens; Robert Landewé
Biochemical markers of joint tissue turnover in early rheumatoid arthritis.
Clinical and experimental rheumatology 2003;21(5 Suppl 31):S54-8.
2003: Piet Geusens; Koen Milisen; Eddy Dejaeger; Steven Boonen
Falls and fractures in postmenopausal women: a review.
The journal of the British Menopause Society 2003;9(3):101-6.
2003: Lavienja A J L M Braam; Marjo H J Knapen; Piet Geusens; Fred Brouns; Karly Hamulyák; M J W Gerichhausen; Cees Vermeer
Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age.
Calcified tissue international 2003;73(1):21-6.
2003: Johan Vanhoof; S Landewe; J Vandevenne; Piet Geusens
An exceptional radiographic presentation of bilateral insufficiency fractures of the proximal tibia in a patient with rheumatoid arthritis.
Annals of the rheumatic diseases 2003;62(3):277-9.
2002: Patrick Garnero; Robert Landewé; Maarten Boers; Arco Verhoeven; Sjef van der Linden; Stephan Christgau; Désirée van der Heijde; Annelies Boonen; Piet Geusens
Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study.
Arthritis and rheumatism 2002;46(11):2847-56.
2002: Piet Geusens; Marc C Hochberg; Danny J M van der Voort; Huibert A P Pols; Marjolein Van der Klift; Ethel S Siris; Mary E Melton; Jennifer Turpin; Christine Byrnes; Philip Ross
Performance of risk indices for identifying low bone density in postmenopausal women.
Mayo Clinic proceedings. Mayo Clinic 2002;77(7):629-37.
2002: Piet Geusens; Philip Autier; Steven Boonen; Johan Vanhoof; Kathy Declerck; Jef Raus
The relationship among history of falls, osteoporosis, and fractures in postmenopausal women.
Archives of physical medicine and rehabilitation 2002;83(7):903-6.
2002: Johan Vanhoof; Kathy Declerck; Piet Geusens
Prevalence of rheumatic diseases in a rheumatological outpatient practice.
Annals of the rheumatic diseases 2002;61(5):453-5.
2002: Steven Boonen; Clifford Rosen; Roger Bouillon; Andreas Sommer; Malcolm McKay; David Rosen; Steven Adams; P L O Broos; Jean-Pierre Lenaerts; Jef Raus; Dirk Vanderschueren; Piet Geusens
Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study.
The Journal of clinical endocrinology and metabolism 2002;87(4):1593-9.
2002: Mieke Buntinx; Marcel Ameloot; Paul Steels; Paul Janssen; Robert Medaer; Piet Geusens; Jef Raus; Piet Stinissen
Interferon-gamma-induced calcium influx in T lymphocytes of multiple sclerosis and rheumatoid arthritis patients: a complementary mechanism for T cell activation?
Journal of neuroimmunology 2002;124(1-2):70-82.
2002: Ann VanderBorght; Filip De Keyser; Piet Geusens; Marc De Backer; Michel Malaise; Dominique Baeten; Filip Van den Bosch; Eric M Veys; Jef Raus; Piet Stinissen
Dynamic T cell receptor clonotype changes in synovial tissue of patients with early rheumatoid arthritis: effects of treatment with cyclosporin A (Neoral).
The Journal of rheumatology 2002;29(3):416-26.
2002: Piet Geusens; Steven Boonen
Osteoporosis and the growth hormone-insulin-like growth factor axis.
Hormone research 2002;58 Suppl 3():49-55.
2001: Piet Geusens; M McClung
Review of risedronate in the treatment of osteoporosis.
Expert opinion on pharmacotherapy 2001;2(12):2011-25.
2001: CR Dhore; Jack P M Cleutjens; Esther Lutgens; Kitty B J M Cleutjens; Piet Geusens; Peter J E H M Kitslaar; Jan H M Tordoir; Henri M H Spronk; Cees Vermeer; Mat J A P Daemen
Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(12):1998-2003.
2001: Ann VanderBorght; Piet Geusens; Jef Raus; Piet Stinissen
The autoimmune pathogenesis of rheumatoid arthritis: role of autoreactive T cells and new immunotherapies.
Seminars in arthritis and rheumatism 2001;31(3):160-75.
2001: Arco Verhoeven; Maarten Boers; Johan teKoppele; W H van der Laan; Harry M Markusse; Piet Geusens; Sjef van der Linden
Bone turnover, joint damage and bone mineral density in early rheumatoid arthritis treated with combination therapy including high-dose prednisolone.
Rheumatology (Oxford, England) 2001;40(11):1231-7.
2001: Piet Geusens; Debby Vosse; Désirée van der Heijde; Johan Vanhoof; Astrid van Tubergen; Jef Raus; Sjef van der Linden
High prevalence of thoracic vertebral deformities and discal wedging in ankylosing spondylitis patients with hyperkyphosis.
The Journal of rheumatology 2001;28(8):1856-61.
2001: Piet Geusens; Johan Menten; Debby Vosse; Johan Vanhoof; S van der Linden
Recovery from severe glucocorticoid-induced osteoporosis in an adolescent boy.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2001;4(4):389-94.
2001: Danny J M van der Voort; Piet Geusens; Geert-Jan Dinant
Risk factors for osteoporosis related to their outcome: fractures.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2001;12(8):630-8.
2000: Danny J M van der Voort; Geert-Jan Dinant; P E L M Rinkens; C J van der Voort-Duindam; Jan W J van Wersch; Piet Geusens
Construction of an algorithm for quick detection of patients with low bone mineral density and its applicability in daily general practice.
Journal of clinical epidemiology 2000;53(11):1095-103.
2000: Ann VanderBorght; Piet Geusens; Caroline Vandevyver; Jef Raus; Piet Stinissen
Skewed T-cell receptor variable gene usage in the synovium of early and chronic rheumatoid arthritis patients and persistence of clonally expanded T cells in a chronic patient.
Rheumatology (Oxford, England) 2000;39(11):1189-201.
1999: Caroline Vandevyver; Johan Vanhoof; Kathy Declerck; Piet Stinissen; C Vandervorst; Luc Michiels; JJ Cassiman; Steven Boonen; Jef Raus; Piet Geusens
Lack of association between estrogen receptor genotypes and bone mineral density, fracture history, or muscle strength in elderly women.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1999;14(9):1576-82.
1999: Ann VanderBorght; Annegret Van der Aa; Piet Geusens; Caroline Vandevyver; Jef Raus; Piet Stinissen
Identification of overrepresented T cell receptor genes in blood and tissue biopsies by PCR-ELISA.
Journal of immunological methods 1999;223(1):47-61.
1998: Piet Geusens; Jan Dequeker; Johan Vanhoof; R Stalmans; Steven Boonen; Johan Joly; Jos Nijs; Jef Raus
Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment. A double blind, randomised placebo controlled study.
Annals of the rheumatic diseases 1998;57(12):724-7.
1997: Steven Boonen; Dirk Vanderschueren; XG Cheng; Geert Verbeke; Jan Dequeker; Piet Geusens; P L O Broos; Roger Bouillon
Age-related (type II) femoral neck osteoporosis in men: biochemical evidence for both hypovitaminosis D- and androgen deficiency-induced bone resorption.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1997;12(12):2119-26.
1997: Piet Geusens; Caroline Vandevyver; Johan Vanhoof; JJ Cassiman; Steven Boonen; Jef Raus
Quadriceps and grip strength are related to vitamin D receptor genotype in elderly nonobese women.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1997;12(12):2082-8.
1997: Steven Boonen; Dirk Vanderschueren; Piet Geusens; R Bouillon
Age-associated endocrine deficiencies as potential determinants of femoral neck (type II) osteoporotic fracture occurrence in elderly men.
International journal of andrology 1997;20(3):134-43.
1997: Piet Geusens; Johan Vanhoof; Jef Raus; Jan Dequeker; Jos Nijs; Johan Joly
Treatment with etidronate for men with idiopathic osteoporosis.
Annals of the rheumatic diseases 1997;56(4):280.
1997: L Celis; Caroline Vandevyver; Piet Geusens; J Dequeker; Jef Raus; J Zhang
Clonal expansion of mycobacterial heat-shock protein-reactive T lymphocytes in the synovial fluid and blood of rheumatoid arthritis patients.
Arthritis and rheumatism 1997;40(3):510-9.
1997: Caroline Vandevyver; T Wylin; JJ Cassiman; Jef Raus; Piet Geusens
Influence of the vitamin D receptor gene alleles on bone mineral density in postmenopausal and osteoporotic women.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1997;12(2):241-7.
1996: Piet Geusens; Steven Boonen; Jos Nijs; Y Jiang; G Lowet; R Van Auderkercke; C Huyghe; F Caulin; J M Very; J Dequeker; Georges Van der Perre
Effect of salmon calcitonin on femoral bone quality in adult ovariectomized ewes.
Calcified tissue international 1996;59(4):315-20.
1996: Johan Van Cleemput; Willem Daenen; Piet Geusens; P Dequeker; Frans Van de Werf; Johan Vanhaecke
Prevention of bone loss in cardiac transplant recipients. A comparison of biphosphonates and vitamin D.
Transplantation 1996;61(10):1495-9.
1996: Jeroen Aerssens; Remy Van Audekercke; M Talalaj; Piet Geusens; E Bramm; J Dequeker
Effect of 1alpha-vitamin D3 and estrogen therapy on cortical bone mechanical properties in the ovariectomized rat model.
Endocrinology 1996;137(4):1358-64.
1996: Y Jiang; J Zhao; Remy Van Audekercke; J Dequeker; Piet Geusens
Effects of low-dose long-term sodium fluoride preventive treatment on rat bone mass and biomechanical properties.
Calcified tissue international 1996;58(1):30-9.
1995: Steven Boonen; R Koutri; J Dequeker; Jeroen Aerssens; G Lowet; Jos Nijs; Geert Verbeke; Emmanuel Lesaffre; Piet Geusens
Measurement of femoral geometry in type I and type II osteoporosis: differences in hip axis length consistent with heterogeneity in the pathogenesis of osteoporotic fractures.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1995;10(12):1908-12.
1995: Piet Geusens
Nandrolone decanoate: pharmacological properties and therapeutic use in osteoporosis.
Clinical rheumatology 1995;14 Suppl 3():32-9.
1995: Caroline Vandevyver; Piet Geusens; J J Cassiman; J Raus
Peptide transporter genes (TAP) polymorphisms and genetic susceptibility to rheumatoid arthritis.
British journal of rheumatology 1995;34(3):207-14.
1995: Johan Van Cleemput; Willem Daenen; Jos Nijs; Piet Geusens; J Dequeker; Johan Vanhaecke
Timing and quantification of bone loss in cardiac transplant recipients.
Transplant international : official journal of the European Society for Organ Transplantation 1995;8(3):196-200.
1994: Caroline Vandevyver; Piet Geusens; J J Cassiman; J Raus
T cell receptor delta locus polymorphism in rheumatoid arthritis.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1994;21(6):479-83.
1994: Jeroen Aerssens; Remy Van Audekercke; M Talalaj; P Van Vlasselaer; E Bramm; Piet Geusens; J Dequeker
Effect of 1 alpha-vitamin D3 on bone strength and composition in growing rats with and without corticosteroid treatment.
Calcified tissue international 1994;55(6):443-50.
1994: Willem Proesmans; G Goos; francesco emma; Piet Geusens; Jos Nijs; J Dequeker
Total body mineral mass measured with dual photon absorptiometry in healthy children.
European journal of pediatrics 1994;153(11):807-12.
1994: Johan Verhaeghe; A M Suiker; T A Einhorn; Piet Geusens; W J Visser; Erik Van Herck; Rita van Bree; S Magitsky; Roger Bouillon
Brittle bones in spontaneously diabetic female rats cannot be predicted by bone mineral measurements: studies in diabetic and ovariectomized rats.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1994;9(10):1657-67.
1994: Dirk Vanderschueren; Erik Van Herck; Piet Geusens; A Suiker; W Visser; K Chung; Roger Bouillon
Androgen resistance and deficiency have different effects on the growing skeleton of the rat.
Calcified tissue international 1994;55(3):198-203.
1994: Caroline Vandevyver; X X Gu; Piet Geusens; M Spaepen; L Philippaerts; Jean-Jacques Cassiman; Jef Raus
HLA class II and T-cell receptor beta chain polymorphisms in Belgian patients with rheumatoid arthritis: no evidence for disease association with the TCRBC2, TCRBV8 and TCRBV11 polymorphisms.
Annals of the rheumatic diseases 1994;53(9):580-6.
1994: A Abdel-Hamid Osman; H Bassiouni; R Koutri; Jos Nijs; Piet Geusens; J Dequeker
Aging of the thoracic spine: distinction between wedging in osteoarthritis and fracture in osteoporosis--a cross-sectional and longitudinal study.
Bone 1994;15(4):437-42.
1994: Piet Geusens; C Wouters; Jos Nijs; Y Jiang; J Dequeker
Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study.
Arthritis and rheumatism 1994;37(6):824-9.
1993: Dirk Vanderschueren; Erik Van Herck; P Schot; E Rush; T Einhorn; Piet Geusens; Roger Bouillon
The aged male rat as a model for human osteoporosis: evaluation by nondestructive measurements and biomechanical testing.
Calcified tissue international 1993;53(5):342-7.
1993: Jeroen Aerssens; Remy Van Audekercke; Piet Geusens; L P Schot; A A Osman; J Dequeker
Mechanical properties, bone mineral content, and bone composition (collagen, osteocalcin, IGF-I) of the rat femur: influence of ovariectomy and nandrolone decanoate (anabolic steroid) treatment.
Calcified tissue international 1993;53(4):269-77.
1992: Dirk Vanderschueren; Erik Van Herck; A M Suiker; K Allewaert; W J Visser; Piet Geusens; Roger Bouillon
Bone and mineral metabolism in the adult guinea pig: long-term effects of estrogen and androgen deficiency.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1992;7(12):1407-15.
1992: G Raymaekers; Jeroen Aerssens; R Van den Eynde; J Peeters; Piet Geusens; P Devos; J Dequeker
Alterations of the mineralization profile and osteocalcin concentrations in osteoarthritic cortical iliac crest bone.
Calcified tissue international 1992;51(4):269-75.
1992: Jean-Yves Reginster; F Colson; G Morlock; B Combe; D Ethgen; Piet Geusens
Evaluation of the efficacy and safety of oral tiludronate in Paget's disease of bone. A double-blind, multiple-dosage, placebo-controlled study.
Arthritis and rheumatism 1992;35(8):967-74.
1992: A Sileghem; Piet Geusens; J Dequeker
Intranasal calcitonin for the prevention of bone erosion and bone loss in rheumatoid arthritis.
Annals of the rheumatic diseases 1992;51(6):761-4.
1992: Piet Geusens; Jos Nijs; Georges Van der Perre; Remy Van Audekercke; G Lowet; S Goovaerts; A Barbier; Frederic Lacheretz; B Remandet; Y Jiang
Longitudinal effect of tiludronate on bone mineral density, resonant frequency, and strength in monkeys.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1992;7(6):599-609.
1991: Piet Geusens; Dirk Vanderschueren; A Verstraeten; J Dequeker; P Devos; Roger Bouillon
Short-term course of 1,25(OH)2D3 stimulates osteoblasts but not osteoclasts in osteoporosis and osteoarthritis.
Calcified tissue international 1991;49(3):168-73.
1991: H Verlooy; J Dequeker; Piet Geusens; Jos Nijs; M Goris
Body composition by intercomparison of underwater weighing, skinfold measurements and dual-photon absorptiometry.
The British journal of radiology 1991;64(764):765-7.
1991: Piet Geusens; L P Schot; Jos Nijs; J Dequeker
Calcium-deficient diet in ovariectomized dogs limits the effects of 17 beta-estradiol and nandrolone decanoate on bone.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1991;6(8):791-7.
1991: Dirk Vanderschueren; G Gevers; J Dequeker; Piet Geusens; Jos Nijs; P Devos; M De Roo; Roger Bouillon
Seasonal variation in bone metabolism in young healthy subjects.
Calcified tissue international 1991;49(2):84-9.
1991: Piet Geusens; J Dequeker; J Gielen; L P Schot
Non-linear increase in vertebral density induced by a synthetic steroid (Org OD 14) in women with established osteoporosis.
Maturitas 1991;13(2):155-62.
1991: J Dequeker; L Tobing; V Rutten; Piet Geusens
Relative risk factors for osteoporotic fracture: a pilot study of the MEDOS questionnaire.
Clinical rheumatology 1991;10(1):49-53.
1991: A Verstraeten; H Van Ermen; G Haghebaert; Jos Nijs; Piet Geusens; J Dequeker
Osteoarthrosis retards the development of osteoporosis. Observation of the coexistence of osteoarthrosis and osteoporosis.
Clinical orthopaedics and related research 1991;(264):169-77.
1991: Piet Geusens; J Dequeker; Jos Nijs; A Verstraeten; E Bramm
Prevention and treatment of osteopenia in the ovariectomized rat: effect of combined therapy with estrogens, 1-alpha vitamin D, and prednisolone.
Calcified tissue international 1991;48(2):127-37.
1991: J Dequeker; Piet Geusens; A Verstraeten; Dirk Vanderschueren; Jos Nijs
1,25-Dihydroxyvitamin D3 stimulation test and the effect of a prostaglandin synthesis inhibitor (piroxicam) in young adults.
Mineral and electrolyte metabolism 1991;17(6):353-6.
1991: Piet Geusens; F Cantatore; Jos Nijs; Willem Proesmans; francesco emma; J Dequeker
Heterogeneity of growth of bone in children at the spine, radius and total skeleton.
Growth, development, and aging : GDA 1991;55(4):249-56.
1990: Piet Geusens; J Dequeker; Jos Nijs; E Bramm
Effect of ovariectomy and prednisolone on bone mineral content in rats: evaluation by single photon absorptiometry and radiogrammetry.
Calcified tissue international 1990;47(4):243-50.
1990: J Dequeker; Piet Geusens
Osteoporosis and arthritis.
Annals of the rheumatic diseases 1990;49(5):276-80.
1990: J Dequeker; Piet Geusens
Treatment of established osteoporosis and rehabilitation: current practice and possibilities.
Maturitas 1990;12(1):1-36.
1989: A Verstraeten; J Dequeker; Jos Nijs; Piet Geusens
Prevention of postmenopausal bone loss in rheumatoid arthritis patients. A two-year prospective study.
Clinical and experimental rheumatology 1989;7(4):351-8.
1989: Jean-Yves Reginster; Piet Geusens; Jos Nijs; D Denis; P Franchimont; J Dequeker
In vivo long-term precision of spinal bone mass measurement by dual photon absorptiometry.
Bone and mineral 1989;6(2):225-9.
1989: G Gevers; J Dequeker; Piet Geusens; C Nyssen-Behets; A Dhem
Physical and histomorphological characteristics of iliac crest bone differ according to the grade of osteoarthritis at the hand.
Bone 1989;10(3):173-7.
1988: Johan Auwerx; J Dequeker; Roger Bouillon; Piet Geusens; Jos Nijs
Mineral metabolism and bone mass at peripheral and axial skeleton in diabetes mellitus.
Diabetes 1988;37(1):8-12.
1987: J Dequeker; Jos Nijs; A Verstraeten; Piet Geusens; G Gevers
Genetic determinants of bone mineral content at the spine and radius: a twin study.
Bone 1987;8(4):207-9.
1986: Piet Geusens; J Dequeker; A Verstraeten; Jos Nijs; Marnix van Holsbeeck
Bone mineral content, cortical thickness and fracture rate in osteoporotic women after withdrawal of treatment with nandrolone decanoate, 1-alpha hydroxyvitamin D3, or intermittent calcium infusions.
Maturitas 1986;8(4):281-9.
1986: Piet Geusens; J Dequeker; A Verstraeten; Jos Nijs
Age-, sex-, and menopause-related changes of vertebral and peripheral bone: population study using dual and single photon absorptiometry and radiogrammetry.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1986;27(10):1540-9.
1986: Piet Geusens; J Dequeker
Long-term effect of nandrolone decanoate, 1 alpha-hydroxyvitamin D3 or intermittent calcium infusion therapy on bone mineral content, bone remodeling and fracture rate in symptomatic osteoporosis: a double-blind controlled study.
Bone and mineral 1986;1(4):347-57.
1985: A Verstraeten; J Dequeker; Piet Geusens
Metabolic bone disease in rheumatoid arthritis and osteoarthritis.
Annals of the rheumatic diseases 1985;44(4):283-4.
1983: Piet Geusens; J Dequeker; A Verstraeten
Age-related blood changes in hip osteoarthritis patients: a possible indicator of bone quality.
Annals of the rheumatic diseases 1983;42(1):112-3.